HA-ADT inhibited HCC cells via promoting apoptosis via suppressing the AKT/GSK-3β/β-catenin, and inhibiting autophagy through suppressing TGF-β/Smad2/3 signaling pathways. Here, GSK3B is linked to hepatocellular carcinoma.